Rupesh Rajesh Kotecha, MD
Dr. Rupesh Rajesh Kotecha is a board-certified radiation oncologist at Baptist Health’s Miami Cancer Institute. He has special skills and experience in the use of innovative techniques for both malignant and non-cancerous conditions, including malignant pleural mesothelioma and other thoracic malignancies.[1]
Dr. Kotecha performs numerous high-level procedures that leverage advancements in radiation oncology, including:[3]
- 3-D conformal radiotherapy
- Brachytherapy
- External beam radiotherapy
- Gamma Knife radiosurgery
- Cyberknife radiosurgery
- Image-guided radiation therapy
- Intensity-modulated radiation therapy
- Stereotactic body radiotherapy
- Stereotactic ablative radiotherapy
- Re-irradiation
- Spatially fractionated radiotherapy
- MR-guided radiotherapy
- Proton beam radiotherapy
- Cardiac radiosurgery
Education and Career
Dr. Kotecha earned his medical degree at Michigan State University College of Human Medicine in East Lansing, Michigan. He completed his internship and residency in Radiation Oncology at Cleveland Clinic’s Taussig Cancer Institute in Cleveland, Ohio.[1]
In addition to being Chief of Radiosurgery in the Department of Radiation Oncology and the Director of the Central Nervous System Metastasis program at Miami Cancer Institute, he is also an Adjunct Faculty at Memorial Sloan Kettering Cancer Center in New York.
Dr. Kotecha serves as the CNS co-chair for the Proton Collaborative Group, coordinates the NCI Glioblastoma Clinical Working Group, and is a course director for the annual Miami Brain Symposium. He is an editorial contributor and advisory board member on the topic of brain cancer for Practice Update, an online resource for healthcare providers throughout the United States and the world.
Research
Dr. Kotecha is actively involved in researching the use of stereotactic radiosurgery and stereotactic body radiation therapy in the management of both brain metastases and thoracic malignancies like malignant pleural mesothelioma. He has a particular interest in the use of CyberKnife, LINAC-based and GammaKnife radiosurgery, and tumor-treating fields. He is frequently invited to speak on innovations in radiation therapy at national and international symposiums and has published multiple book chapters and dozens of articles in peer-reviewed journals, including the Journal of Clinical Oncology, International Journal of Radiation Oncology Biology Physics, Cancer, and Practical Radiation Oncology.[1]
Dr. Kotecha’s recent publications include:[2]
- Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy. Rupesh Kotecha, Raees Tonse, Muni Rubens, Haley Appel, Federico Albrecht, Paul Kaywin, Evan W. Alley, Martin C. Tom, Minesh P. Mehta. Cancers (Basel) 2021 May; 13(9): 2186. Published online 2021 May 2. doi: 10.3390/cancers13092186. PMCID: PMC8124134. ArticlePDF–1.6M. Select item 9873416
- Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region. Milan J. Anadkat, Mario Lacouture, Adam Friedman, Zachary D. Horne, Jae Jung, Benjamin Kaffenberger, Sujith Kalmadi, Liza Ovington, Rupesh Kotecha, Huda Ismail Abdullah, Federica Grosso. Front Oncol. 2022; 12: 975473. Published online 2023 Jan 4. doi: 10.3389/fonc.2022.975473. PMCID: PMC9873416. ArticlePDF–1.0M. Select item 10297418
- Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma. Tugce Kutuk, Joshua M. Walker, Matthew T. Ballo, Robert B. Cameron, Jean Bustamante Alvarez, Sheema Chawla, Eric Luk, Deepti Behl, Alan Dal Pra, Neil Morganstein, Tamer Refaat, Arshin Sheybani, Christian Squillante, Jun Zhang, Rupesh Kotecha. Curr Oncol. 2023 Jun; 30(6): 5195–5200. Published online 2023 May 23. doi: 10.3390/curroncol30060394. PMCID: PMC10297418. ArticlePDF–613K Select item 9032984
- Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data. Tugce Kutuk, Haley Appel, Maria Carolina Avendano, Federico Albrecht, Paul Kaywin, Suyen Ramos, Melanie E. Suarez-Murias, Minesh P. Mehta, Rupesh Kotecha. Cancers (Basel) 2022 Apr; 14(8): 2020. Published online 2022 Apr 16. doi: 10.3390/cancers14082020. PMCID: PMC9032984
